CASCAT builds a kNN cell graph, prunes conditionally independent edges via kernel-smoothed conditional mutual information (PIDC-derived), refines embeddings with graph structure learning (STAGUE-inspired), then infers a unique, acyclic trajectory using a tree-shaped structural causal model that enforces Markovian state transitions. The authors report the lowest average Ipsen-Mikhailov similarity (0.3315 vs 0.4721 for Monocle3) across 10 dyngen-simulated scRNA-seq datasets, plus the highest average KT (0.7795) and SR (0.9188) scores, and best ARI (0.5095)/AMI (0.5300) across 13 real ST datasets spanning STARmap, MERFISH, and 10x Visium.
In OSCC drug-response prediction, the causality approach reached Cohen's ΞΊ = 0.17 vs 0.05 for RNA velocity, and AUC 0.654 (a 12.3% improvement), using in silico perturbations simulated with Dynamo rather than experimentally measured responses.
Strengths: Broad benchmarking (30 datasets, 3 ST platforms, 5 random seeds), clear ablation showing CMI and GSL each contribute significantly (p < 0.05), and released code/data on Figshare support reproducibility.
Limitations the authors partially acknowledge: (1) No ground-truth pseudotime exists for ST dataβspatial benchmarks rely on ARI/AMI clustering proxies, conflating domain segmentation quality with trajectory accuracy; (2) the tree assumption breaks for cyclic dynamics (cell cycle handled only via a supplementary MI method); (3) CMI estimation is sensitive to k, dropout proportion p, and zero-inflated count noise; (4) drug predictions are in silico (Dynamo-simulated) with no wet-lab validation, and absolute ΞΊ values (0.17) remain weak agreement, so the 3.4Γ relative gain should not be over-read. (5) The stated "6.8% precision increase" vs velocity methods is modest in absolute terms. The method's claim of "causality" rests on conditional-independence tests, which can be confounded by latent variablesβa general caveat for CMI-based structure learning.
Context: CASCAT fits a crowded fieldβspatial transcriptomics tooling is proliferating rapidly (e.g., platform-agnostic pipelines like SpaceSequest, review-level surveys note dozens of competing methods with limited standardized benchmarking).
Independent validation on datasets with orthogonal trajectory ground truth (lineage tracing, time-course ST), head-to-head benchmarking against newer spatial methods, and experimental confirmation of at least one OSCC drug prediction would substantially strengthen the causal claims. Without these, CASCAT is a well-engineered incremental advanceβprincipled, well-benchmarked, but its causal language outpaces its causal evidence.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.